On April 9, 2026, Oxford BioTherapeutics announced a multi-year collaboration with Bristol Myers Squibb focused on the discovery and development of T-cell engager therapies for solid tumors. 1 ...
19hon MSN
AI+ smartphone launches Nova series with customisable technology, expands into tablets and wearables
This expansion aims to create a connected ecosystem. The devices emphasize simplicity, privacy, and everyday functionality.
11hon MSN
Microsoft Moves: Longtime exec Julia Liuson to retire; new accessibility chief; and other changes
Big tech moves today from Microsoft: Longtime executive Julia Liuson is leaving, Neil Barnett is the company's new chief ...
Here’s the story behind Microsoft’s graphical branding and four-colored logo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results